HYPERORNITHINAEMIA-HYPERAMMONAEMIA-HOMOCITRULLINURIA SYNDROME

This adverse event was reported 1 times

These drugs are most commonly taken by patients reporting HYPERORNITHINAEMIA-HYPERAMMONAEMIA-HOMOCITRULLINURIA SYNDROME:

# Drug Count
0 CARGLUMIC ACID 1
See all common drugs associated with HYPERORNITHINAEMIA-HYPERAMMONAEMIA-HOMOCITRULLINURIA SYNDROME

HYPERORNITHINAEMIA-HYPERAMMONAEMIA-HOMOCITRULLINURIA SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CARGLUMIC ACID 1 0.0013
See all drugs enriched for association with HYPERORNITHINAEMIA-HYPERAMMONAEMIA-HOMOCITRULLINURIA SYNDROME

These drug classes are most commonly taken by patients reporting HYPERORNITHINAEMIA-HYPERAMMONAEMIA-HOMOCITRULLINURIA SYNDROME:

# Drug class Count
0 Carbamoyl Phosphate Synthetase 1 Activator [EPC] 1
See all common drug classes associated with HYPERORNITHINAEMIA-HYPERAMMONAEMIA-HOMOCITRULLINURIA SYNDROME

HYPERORNITHINAEMIA-HYPERAMMONAEMIA-HOMOCITRULLINURIA SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Carbamoyl Phosphate Synthetase 1 Activator [EPC] 1 0.0013
See all drug classes enriched for association with HYPERORNITHINAEMIA-HYPERAMMONAEMIA-HOMOCITRULLINURIA SYNDROME